Gestational Diabetes Mellitus (GDM) is a significant health concern, affecting up to 14% of pregnancies worldwide. It not only poses immediate risks to the mother and fetus but also increases the long-term risk of type 2 diabetes and cardiovascular diseases. Hence, optimizing GDM management is crucial.
Early detection and diagnosis of GDM can significantly improve pregnancy outcomes. Universal screening for GDM at 24-28 weeks of gestation using oral glucose tolerance test is recommended. For high-risk women, early screening in the first trimester should be considered.
First-line management of GDM involves lifestyle modifications. A balanced diet rich in fiber and low in simple sugars, along with moderate-intensity exercise for at least 30 minutes a day, can help control blood glucose levels. Regular self-monitoring of blood glucose is also essential.
If lifestyle modifications are insufficient, pharmacological interventions may be required. Insulin therapy is the gold standard for GDM management. However, oral hypoglycemic agents like metformin and glyburide are gaining acceptance due to their convenience and cost-effectiveness.
Postpartum follow-up is vital as GDM increases the risk of developing type 2 diabetes later in life. An oral glucose tolerance test should be performed at 6-12 weeks postpartum. Thereafter, regular screening for diabetes is recommended.
Optimal management of GDM requires a multifaceted approach, including early detection, lifestyle modifications, pharmacological interventions, and postpartum follow-up. By adhering to these strategies, healthcare professionals can significantly improve maternal and fetal outcomes while reducing the long-term risk of type 2 diabetes and cardiovascular diseases.
1.
MRI can save rectal cancer patients from surgery, study suggests
2.
When Healthcare Chatbots Fall Short of Human Connection
3.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
4.
Antibiotic Use in Hospice Linked to Higher Mortality Risk
5.
Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status
1.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
2.
Genetic Screening: A Game Changer in Cancer Prevention
3.
All You Need to Know About Mesna: The Ultimate Guide
4.
Unveiling the Hidden Causes of Anemia: A Comprehensive Look at a Common Condition
5.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Innovations in Hematology
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Blood Clotting Disorders Explained
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation